DIRECTIONAL GENOMIC HYBRIDIZATION

Welcome to the Brand page for “DIRECTIONAL GENOMIC HYBRIDIZATION”, which is offered here for Dna microarrays; probes for scientific purposes;cell growth media for growing cells for medical or clinical use; cells for medical or clinical use; cells for medical use; immunoassay reagents for medical use; solutions for medical and clinical use in storing and treating cells, blood and blood components; culture media for cultivating blood; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; stem cells for medical or veterinary use;business consulting and management in the field of clinical trials, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business consulting and management in the field of clinical trials, providing information management services;assays and reagents for use in genetic research; assays for research purposes; reagents for scientific or medical research use; cell culture reagents for scientific and research use; cell growth media for growing cells for scientific and research use; cells for scientific and research use; diagnostic reagents for clinical or medical laboratory use; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; nucleotides for scientific and research use; reagent kits comprising generic dna circle, dna primers, polymerase and buffers for use in biotechnology fields; testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use;dna screening for medical purposes;diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing;custom design and development of chemical reagents and biochemical assays; dna analysis services for scientific research purposes; dna analysis services to determine paternity; dna screening for scientific research purposes; medical and scientific research, conducting clinical trials for others; medical research in the field of oncology; scientific research; scientific research and development; scientific research consulting; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of genetics and genetic engineering; cell culture services for scientific and research purposes, for others; culturing of cells for others for scientific research purposes; medical and scientific research in the field of cancer treatment and diagnosis; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing reagent sample testing and diagnostic services for others for scientific research purposes;.

Its status is currently believed to be active. Its class is unavailable. “DIRECTIONAL GENOMIC HYBRIDIZATION” is believed to be currently owned by “KromaTiD Inc.”